#Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?

Randeep Dhariwal*, Nisha Pindoria, Prokar Dasgupta, Muhammad S. Khan

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)203-207
Number of pages5
JournalBJU International
Issue number2
Publication statusPublished - 1 Feb 2019


  • atezolizumab
  • bladder cancer
  • checkpoint inhibitors
  • immunotherapy
  • metastatic urothelial carcinoma
  • pembrolizumab

Cite this